Country of origin

Lisdexamfetamine | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Lisdexamfetamine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

MOQ: 1 kg
Type: Producer
Origin: United States
United States

MOQ: 1 kg
Type: Producer
Origin: India

Looking for Lisdexamfetamine 608137-32-2?

API | Excipient name:
Lisdexamfetamine, lisdexamfetamine dimesylate  
Cas Number:
DrugBank number:
Unique Ingredient Identifier:

About Lisdexamfetamine

What makes Lisdexamfetamine unique? Also known as Vyvanse, lisdexamfetamine (L-lysine-d-amphetamine) is a prodrug of the psychostimulant d-amphetamine It is paired with the essential amino acid L-lysine. Lisdexamfetamine dimesylate increases attention span and decreases restlessness in children and adults who are overactive/hyperactive, cannot concentrate for long periods, or are easily distracted or impulsive As a central nervous system stimulant, lisdexamfetamine is utilized as an adjunct therapy in the treatment of attention deficit hyperactivity disorder (ADHD). As a prodrug, lisdexamfetamine was specifically engineered as an abuse-resistant product.

You can ask the supplier for more technical information about the product.

Lisdexamfetamine manufacturers | traders | suppliers
We have 2 companies offering Lisdexamfetamine from 2 different countries.

Get in contact with the supplier of your choice:

  • Noramco from United States
  • Embio from India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.